Am J Health-Syst Pharm
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow A correction has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Murphy, J. E.
Right arrow Articles by Roether, A. M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Murphy, J. E.
Right arrow Articles by Roether, A. M.
American Journal of Health-System Pharmacy, Vol. 65, Issue 7, 624-630
Copyright © 2008. American Society of Health-System Pharmacists, Inc. All rights reserved. 1079-2082/04/0602-1242$06.00


Clinical Report

Two nomograms for determining extended-dosing intervals for gentamicin in neonates

John E. Murphy and Anthony M. Roether

JOHN E. MURPHY, PHARMD., FCCP, FASHP, is Professor of Pharmacy. Practice and Science and Associate Dean for Academic and Professional Affairs, College of Pharmacy, University of Arizona, Tucson. ANTHONY M. ROETHER, PHARM.D., is Pharmacist, United Drugs, Tucson.

Address correspondence to Dr. Murphy at the College of Pharmacy, University of Arizona, P.O. Box 210202, Tucson, AZ 85721-0202 (murphy{at}pharmacy.arizona.edu).


Purpose. The development of two nomograms to predict dosing intervals for gentamicin in neonates based on one gentamicin concentration is described.

Methods. Pooled data from three retrospective studies on neonates age seven days or younger were used to create nomograms that would predict dosing intervals for gentamicin. The population volume of distribution (0.45 L/kg) and a determined half-life were used to create nomogram cutoff concentrations that could select a dosing interval for neonates to achieve steady-state trough concentrations of ≤0.5 or ≤1 mg/L. A dose of 4 mg/kg was used to simulate concentration-versus-time profiles for included neonates based on their individual pharmacokinetic data. Predicted concentrations from hours 6 to 22, at one-hour intervals, for each neonate were compared against the nomograms and evaluated for the number of correct interval predictions. The nomograms were considered to have failed at any time point where they indicated an interval that would not have achieved the desired trough concentration of ≤0.5 or ≤1 mg/L or if the interval chosen was longer than necessary.

Results. The 0.5- and 1-mg/L nomograms predicted correct dosing intervals for 81–92% of neonates for postinfusion hours between 15 to 21 and 86–93% for postinfusion hours of 13 and 21, respectively. Accuracy of the nomograms to predict correct dosing intervals improved as the postinfusion time before the next concentration measurement increased.

Conclusion. Using the two nomograms may help predict the correct extended-dosing intervals of gentamicin administration for neonates. Prospective evaluation and validation of the nomograms may be necessary for their wider use as a clinical tool.

Index terms: Aminoglycosides; Blood levels; Dosage; Drugs, body distribution; Gentamicin; Half-life; Injections; Methodology; Nomograms; Pediatrics; Pharmacokinetics

 






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Society of Health-System Pharmacists.